...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
【24h】

Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.

机译:Noggin和BMP4在Alzheimer病APP(swe)/ PS1(DeltaE9)转基因小鼠模型中共同调节成年海马神经发生。

获取原文
获取原文并翻译 | 示例
           

摘要

In addition to the subventricular zone, the dentate gyrus of the hippocampus is one of the few brain regions in which neurogenesis continues into adulthood. Perturbation of neurogenesis can alter hippocampal function, and previous studies have shown that neurogenesis is dysregulated in Alzheimer disease (AD) brain. Bone morphogenetic protein-4 (BMP4) and its antagonist Noggin have been shown to play important roles both in embryonic development and in the adult nervous system, and may regulate hippocampal neurogenesis. Previous data indicated that increased expression of BMP4 mRNA within the dentate gyrus might contribute to decreased hippocampal cell proliferation in the APP(swe)/PS1(DeltaE9) mouse AD model. However, it is not known whether the BMP antagonist Noggin contributes to the regulation of neurogenesis. We therefore studied the relative expression levels and localization of BMP4 and its antagonist Noggin in the dentate gyrus and whether these correlated with changes in neurogenesis in 6-12 mo old APP(swe)/PS1(DeltaE9) transgenic mice. Bromodeoxyuridine (BrdU) was used to label proliferative cells. We report that decreased neurogenesis in the APP/PS1 transgenic mice was accompanied by increased expression of BMP4 and decreased expression of Noggin at both the mRNA and protein levels; statistical analysis showed that the number of proliferative cells at different ages correlated positively with Noggin expression and negatively with BMP4 expression. Intraventricular administration of a chimeric Noggin/Fc protein was used to block the action of endogenous BMP4; this resulted in a significant increase in the number of BrdU-labeled cells in dentate gyrus subgranular zone and hilus in APP/PS1 mice. These results suggest that BMP4 and Noggin co-modulate neurogenesis.
机译:除脑室下区外,海马的齿状回是神经发生持续到成年的少数大脑区域之一。神经发生的扰动可以改变海马功能,以前的研究表明,阿尔茨海默病(AD)脑中神经发生失调。骨形态发生蛋白4(BMP4)及其拮抗剂Noggin已显示在胚胎发育和成年神经系统中均起重要作用,并可能调节海马神经发生。先前的数据表明,在APP(swe)/ PS1(DeltaE9)小鼠AD模型中,齿状回中BMP4 mRNA的表达增加可能有助于海马细胞增殖的降低。但是,尚不清楚BMP拮抗剂Noggin是否有助于调节神经发生。因此,我们研究了BMP4及其拮抗剂Noggin在齿状回中的相对表达水平和定位,以及它们是否与6-12个月大的APP(swe)/ PS1(DeltaE9)转基因小鼠的神经发生变化有关。溴脱氧尿苷(BrdU)用于标记增殖细胞。我们报道在APP / PS1转基因小鼠中神经发生的减少伴随着BMP4表达的增加和Noggin在mRNA和蛋白水平上的表达的降低。统计分析表明,不同年龄的增殖细胞数目与Noggin表达呈正相关,与BMP4表达呈负相关。嵌合Noggin / Fc蛋白的脑室内给药可阻断内源性BMP4的作用。这导致APP / PS1小鼠的齿状回亚颗粒区和hilus中BrdU标记的细胞数量显着增加。这些结果表明,BMP4和Noggin共同调节神经发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号